YU401A - Sredstva sa antidepresivnim dejstvom - Google Patents

Sredstva sa antidepresivnim dejstvom

Info

Publication number
YU401A
YU401A YU401A YU401A YU401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A
Authority
YU
Yugoslavia
Prior art keywords
agents
antidepressive effect
antidepressive
effect
benzothizole
Prior art date
Application number
YU401A
Other languages
English (en)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg. filed Critical Boehringer Ingelheim Pharma Kg.
Publication of YU401A publication Critical patent/YU401A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak se odnosi na upotrebu 2-amino-4,5,6,7-tetrahidro-6-propilamino-benzotiazola (pramipeksol), njegovih (+)- ili (-)- enantiomera, ili neke od njegovih farmakološki podnošljivih soli, u kombinaciji sa sertralinom, radi poboljšanog lečenja depresija i depresivnih stanja.[The invention relates to the use of 2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothizole (pramipexol), its (+) or (-) enantiomers or one of its pharmacologically compatible salts, combined with sertralin, for treating depression and depressive conditions more effectively.
YU401A 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom YU401A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung

Publications (1)

Publication Number Publication Date
YU401A true YU401A (sh) 2003-10-31

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
YU401A YU401A (sh) 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom

Country Status (33)

Country Link
US (1) US6255329B1 (sh)
EP (1) EP1093369B1 (sh)
JP (1) JP2002520273A (sh)
KR (1) KR100557692B1 (sh)
CN (1) CN1230168C (sh)
AR (1) AR019896A1 (sh)
AT (1) ATE228365T1 (sh)
AU (1) AU762128B2 (sh)
BG (1) BG64972B1 (sh)
BR (1) BR9911768A (sh)
CA (1) CA2336833C (sh)
CZ (1) CZ294087B6 (sh)
DE (2) DE19830201A1 (sh)
DK (1) DK1093369T3 (sh)
EA (1) EA003142B1 (sh)
EE (1) EE04296B1 (sh)
ES (1) ES2183583T3 (sh)
HK (1) HK1037976A1 (sh)
HU (1) HUP0103922A3 (sh)
ID (1) ID27776A (sh)
IL (1) IL140603A0 (sh)
MY (1) MY117969A (sh)
NO (1) NO20010064L (sh)
NZ (1) NZ509729A (sh)
PL (1) PL195043B1 (sh)
PT (1) PT1093369E (sh)
RS (1) RS49795B (sh)
SK (1) SK284923B6 (sh)
TR (1) TR200100146T2 (sh)
TW (1) TW592698B (sh)
WO (1) WO2000002542A2 (sh)
YU (1) YU401A (sh)
ZA (1) ZA200100090B (sh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
KR20040066890A (ko) * 2001-12-11 2004-07-27 유니버시티 오브 버지니아 페이턴트 파운데이션 근위축성 측삭 경화증 치료를 위한 프라미펙솔의 용도
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP1708706A1 (en) * 2004-01-22 2006-10-11 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション Ｒ（＋）プラミペキソールを用いた神経回復
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
EP2137171A4 (en) 2007-03-14 2010-05-19 Knopp Neurosciences Inc SYNTHESIS OF BENZOTHIAZOLE DIAMINES SUBSTITUTED AND PURIFIED FROM THE CHIRAL PERSPECTIVE
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
RS61539B1 (sr) 2013-07-12 2021-04-29 Knopp Biosciences Llc Lečenje povišenih nivoa eozinofila i/ili bazofila
CA2921381A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
MA51658A (fr) * 2017-04-10 2020-12-02 Chase Therapeutics Corp Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies
EP3645120A4 (en) * 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation NK-1 ANTAGONIST COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF DEPRESSION
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
IL140603A0 (en) 2002-02-10
RS49795B (sr) 2008-06-05
EA003142B1 (ru) 2003-02-27
AR019896A1 (es) 2002-03-20
CZ200177A3 (en) 2001-06-13
KR100557692B1 (ko) 2006-03-07
CN1230168C (zh) 2005-12-07
US6255329B1 (en) 2001-07-03
TR200100146T2 (tr) 2001-07-23
HUP0103922A3 (en) 2002-08-28
BR9911768A (pt) 2001-04-03
NZ509729A (en) 2003-06-30
ID27776A (id) 2001-04-26
CA2336833A1 (en) 2000-01-20
PL345842A1 (en) 2002-01-14
CA2336833C (en) 2008-09-23
AU762128B2 (en) 2003-06-19
NO20010064D0 (no) 2001-01-05
AU5030399A (en) 2000-02-01
HK1037976A1 (en) 2002-03-01
SK284923B6 (sk) 2006-02-02
BG105112A (en) 2001-10-31
EP1093369B1 (de) 2002-11-27
DE19830201A1 (de) 2000-01-13
PT1093369E (pt) 2003-03-31
JP2002520273A (ja) 2002-07-09
TW592698B (en) 2004-06-21
WO2000002542A3 (de) 2000-06-22
HUP0103922A2 (hu) 2002-03-28
SK112001A3 (en) 2001-10-08
ZA200100090B (en) 2002-04-04
EE200100014A (et) 2002-06-17
DK1093369T3 (da) 2002-12-16
WO2000002542A2 (de) 2000-01-20
EE04296B1 (et) 2004-06-15
ES2183583T3 (es) 2003-03-16
BG64972B1 (bg) 2006-11-30
KR20010079491A (ko) 2001-08-22
MY117969A (en) 2004-08-30
DE59903556D1 (de) 2003-01-09
EA200100084A1 (ru) 2001-08-27
ATE228365T1 (de) 2002-12-15
CZ294087B6 (cs) 2004-10-13
CN1308533A (zh) 2001-08-15
PL195043B1 (pl) 2007-08-31
EP1093369A2 (de) 2001-04-25
NO20010064L (no) 2001-03-02

Similar Documents

Publication Publication Date Title
YU401A (sh) Sredstva sa antidepresivnim dejstvom
CA2301899A1 (en) Agent with an antidepressant activity
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG104247A (en) Resorcinol derivatives
BG104780A (en) Inhibitors of phospholipase enzymes
DE60112974D1 (en) Carbolinderivate
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
DE59914814D1 (de) Heterozyklische substituierte amide, deren herstellung und anwendung
MXPA02010088A (es) Derivados de ecteinascidina antitumorales.
DE60216233D1 (en) Carbolinderivate
TR200003071T2 (tr) Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
NO20005290D0 (no) Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
BG105710A (en) 5ht1 antagonists for antidepressant therapy
MY124078A (en) Eletriptan hydrobromide monohydrate
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
IL142803A0 (en) Pharmaceutical compositions containing r-tofisopam
BR0012751A (pt) Benzofuranos serotonérgicos
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
IL139303A0 (en) Treatment of arthritis and other similar conditions